These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

233 related items for PubMed ID: 34106788

  • 1. Effect of rapamycin on mitochondria and lysosomes in fibroblasts from patients with mtDNA mutations.
    Cheema NJ, Cameron JM, Hood DA.
    Am J Physiol Cell Physiol; 2021 Jul 01; 321(1):C176-C186. PubMed ID: 34106788
    [Abstract] [Full Text] [Related]

  • 2. Secondary coenzyme Q10 deficiency triggers mitochondria degradation by mitophagy in MELAS fibroblasts.
    Cotán D, Cordero MD, Garrido-Maraver J, Oropesa-Ávila M, Rodríguez-Hernández A, Gómez Izquierdo L, De la Mata M, De Miguel M, Lorite JB, Infante ER, Jackson S, Navas P, Sánchez-Alcázar JA.
    FASEB J; 2011 Aug 01; 25(8):2669-87. PubMed ID: 21551238
    [Abstract] [Full Text] [Related]

  • 3. β-Lapachone attenuates mitochondrial dysfunction in MELAS cybrid cells.
    Jeong MH, Kim JH, Seo KS, Kwak TH, Park WJ.
    Biochem Biophys Res Commun; 2014 Nov 21; 454(3):417-22. PubMed ID: 25451262
    [Abstract] [Full Text] [Related]

  • 4. Oxidative Insults and Mitochondrial DNA Mutation Promote Enhanced Autophagy and Mitophagy Compromising Cell Viability in Pluripotent Cell Model of Mitochondrial Disease.
    Lin DS, Huang YW, Ho CS, Hung PL, Hsu MH, Wang TJ, Wu TY, Lee TH, Huang ZD, Chang PC, Chiang MF.
    Cells; 2019 Jan 17; 8(1):. PubMed ID: 30658448
    [Abstract] [Full Text] [Related]

  • 5. Impaired Cellular Bioenergetics Causes Mitochondrial Calcium Handling Defects in MT-ND5 Mutant Cybrids.
    McKenzie M, Duchen MR.
    PLoS One; 2016 Jan 17; 11(4):e0154371. PubMed ID: 27110715
    [Abstract] [Full Text] [Related]

  • 6. Altered mitochondrial function in fibroblasts containing MELAS or MERRF mitochondrial DNA mutations.
    James AM, Wei YH, Pang CY, Murphy MP.
    Biochem J; 1996 Sep 01; 318 ( Pt 2)(Pt 2):401-7. PubMed ID: 8809026
    [Abstract] [Full Text] [Related]

  • 7. Compensatory responses of protein import and transcription factor expression in mitochondrial DNA defects.
    Joseph AM, Rungi AA, Robinson BH, Hood DA.
    Am J Physiol Cell Physiol; 2004 Apr 01; 286(4):C867-75. PubMed ID: 14656719
    [Abstract] [Full Text] [Related]

  • 8. Decreased ATP synthesis is phenotypically expressed during increased energy demand in fibroblasts containing mitochondrial tRNA mutations.
    James AM, Sheard PW, Wei YH, Murphy MP.
    Eur J Biochem; 1999 Jan 01; 259(1-2):462-9. PubMed ID: 9914528
    [Abstract] [Full Text] [Related]

  • 9. The addition of ketone bodies alleviates mitochondrial dysfunction by restoring complex I assembly in a MELAS cellular model.
    Frey S, Geffroy G, Desquiret-Dumas V, Gueguen N, Bris C, Belal S, Amati-Bonneau P, Chevrollier A, Barth M, Henrion D, Lenaers G, Bonneau D, Reynier P, Procaccio V.
    Biochim Biophys Acta Mol Basis Dis; 2017 Jan 01; 1863(1):284-291. PubMed ID: 27815040
    [Abstract] [Full Text] [Related]

  • 10. Mitochondrial Transfer of Wharton's Jelly Mesenchymal Stem Cells Eliminates Mutation Burden and Rescues Mitochondrial Bioenergetics in Rotenone-Stressed MELAS Fibroblasts.
    Lin TK, Chen SD, Chuang YC, Lan MY, Chuang JH, Wang PW, Hsu TY, Wang FS, Tsai MH, Huang ST, Wang XW, Tsai PC, Lin HY, Liou CW.
    Oxid Med Cell Longev; 2019 Jan 01; 2019():9537504. PubMed ID: 31249652
    [Abstract] [Full Text] [Related]

  • 11. Different mitochondrial genetic defects exhibit the same protein signature of metabolism in skeletal muscle of PEO and MELAS patients: A role for oxidative stress.
    Santacatterina F, Torresano L, Núñez-Salgado A, Esparza-Molto PB, Olive M, Gallardo E, García-Arumi E, Blazquez A, González-Quintana A, Martín MA, Cuezva JM.
    Free Radic Biol Med; 2018 Oct 01; 126():235-248. PubMed ID: 30138712
    [Abstract] [Full Text] [Related]

  • 12. Accumulation of mtDNA with a mutation at position 3271 in tRNA(Leu)(UUR) gene introduced from a MELAS patient to HeLa cells lacking mtDNA results in progressive inhibition of mitochondrial respiratory function.
    Hayashi J, Ohta S, Takai D, Miyabayashi S, Sakuta R, Goto Y, Nonaka I.
    Biochem Biophys Res Commun; 1993 Dec 30; 197(3):1049-55. PubMed ID: 8280119
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Pioglitazone and Deoxyribonucleoside Combination Treatment Increases Mitochondrial Respiratory Capacity in m.3243A>G MELAS Cybrid Cells.
    Burgin HJ, Lopez Sanchez MIG, Smith CM, Trounce IA, McKenzie M.
    Int J Mol Sci; 2020 Mar 20; 21(6):. PubMed ID: 32244971
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. A novel mutation in the mitochondrial 16S rRNA gene in a patient with MELAS syndrome, diabetes mellitus, hyperthyroidism and cardiomyopathy.
    Hsieh RH, Li JY, Pang CY, Wei YH.
    J Biomed Sci; 2001 Mar 20; 8(4):328-35. PubMed ID: 11455195
    [Abstract] [Full Text] [Related]

  • 18. mTOR inhibitors may benefit kidney transplant recipients with mitochondrial diseases.
    Johnson SC, Martinez F, Bitto A, Gonzalez B, Tazaerslan C, Cohen C, Delaval L, Timsit J, Knebelmann B, Terzi F, Mahal T, Zhu Y, Morgan PG, Sedensky MM, Kaeberlein M, Legendre C, Suh Y, Canaud G.
    Kidney Int; 2019 Feb 20; 95(2):455-466. PubMed ID: 30471880
    [Abstract] [Full Text] [Related]

  • 19. Mitochondrial Dynamics Regulation in Skin Fibroblasts from Mitochondrial Disease Patients.
    Tokuyama T, Hirai A, Shiiba I, Ito N, Matsuno K, Takeda K, Saito K, Mii K, Matsushita N, Fukuda T, Inatome R, Yanagi S.
    Biomolecules; 2020 Mar 13; 10(3):. PubMed ID: 32183225
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.